2019
DOI: 10.1016/j.cpme.2020.100096
|View full text |Cite
|
Sign up to set email alerts
|

Combination of cold plasma and pulsed electric fields – A rationale for cancer patients in palliative care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
13
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 182 publications
0
13
0
Order By: Relevance
“…Moreover, lymphomas are still cancer cells that share several driver mutations with those found in solid tumors. Nevertheless, there are challenges with the applicability of the concept of using PEF and plasma in clinical therapy, which we have outlined previously [25]. Among those are, for example, in melanoma, the location of many metastases beneath the skin in the stratum corneum, which are difficult to reach directly with plasmas.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Moreover, lymphomas are still cancer cells that share several driver mutations with those found in solid tumors. Nevertheless, there are challenges with the applicability of the concept of using PEF and plasma in clinical therapy, which we have outlined previously [25]. Among those are, for example, in melanoma, the location of many metastases beneath the skin in the stratum corneum, which are difficult to reach directly with plasmas.…”
Section: Discussionmentioning
confidence: 99%
“…The supplementation with either antioxidant, a pan-caspase-inhibitor or a ferroptosis inhibitor, all partially rescued lymphoma cells from terminal cell death, which contributes to the mechanistic understanding of this combination treatment.Cancers 2020, 12, 845 2 of 20 mitochondrial/intrinsic to receptor/extrinsic pathways as well as caspase-or Bcl-2 (B-cell lymphoma 2)-independent mechanisms [21][22][23].Pulsed electric fields in the microsecond range (µsPEFs) are used in electrochemotherapy [24]. Application of µsPEF is an accredited anticancer therapy in the clinics [25]. µsPEFs transiently compromise the plasma cell membrane integrity of the cancer cells, allowing the chemotherapeutics, e.g., bleomycin and cisplatin, to enter the cell [26,27].…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The plasma chemistry -particularly the production of reactive species-is expected to differ from a typical APPJs which should open new perspectives of applications. For instance, the EASII-jet configuration offers the opportunity of local production of reactive species with intense pulsed EF desired to trigger biological mechanisms to support alternative cancer therapies 6 . The cheap and simple design of EASII-jet can also be implemented to integrated microfluidic systems to active liquids and surfaces 9 .…”
Section: Discussionmentioning
confidence: 99%
“…Many applications rely on this plasma reactivity in catalysis and materials science processes 3,4 . More generally, APPJs are involved in a large panel of applications such as in medicine to stimulate biological responses 5,6 , agriculture 7 and liquid activation 8,9 . Beyond the non-equilibrium reactive chemistry, APPJs generate guided ionization waves 10 (IWs) -guided streamers 11 -driven by a high electric field (EF) ahead of the discharge channel 12,13 .…”
Section: Introductionmentioning
confidence: 99%